Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis.
A patient initially diagnosed with adductor-type spasmodic dysphonia was referred for botulinum toxin (Botox) injections, but found on subsequent evaluation to have amyotrophic lateral sclerosis, and therefore Botox was not administered. This unique case underscores the need to delay botulinum toxin treatments in any patient with recent onset symptoms, and to obtain thorough motor speech and voice, otolaryngologic, and neurologic evaluation in all patients prior to consideration for injection.
Roth
C R
CR
Department of Speech-Language Pathology, Hennepin Country Medical Center, Minneapolis, MN 55415, USA.
Glaze
L E
LE
Goding
G S
GS
David
W S
WS
D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000503:physiopathology; D001905:Botulinum Toxins / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000175:diagnosis / Q000209:etiology; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D010700:Phonetics; D014827:Vocal Cords / Q000503:physiopathology; D014832:Voice Disorders / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy
D001905:Botulinum Toxins